- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06002763
Evaluering af patientrapporterede udfaldsmålingsinformationssystem (PROMIS)-29 v2.1 for postpartum kvinder
There is no widely used, statistically validated assessment for physical and mental health for the short- to medium-term in a postpartum population. PROMIS-29 has been validated for the assessment of these factors in a generic population, but has not been specifically evaluated for use with postpartum women.
This study is a longitudinal, single center observational cohort study designed to evaluate the reliability of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 survey in a postpartum population. PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living. While this survey has shown utility in other populations, it has yet to be assessed in an obstetric population. The investigators plan to recruit patients who are recently postpartum from vaginal or cesarean delivery to complete virtual surveys at defined time points (0, 2, 6, and 12 weeks after delivery). The investigators will subject survey data to statistical measures of validity and reliability comparing with contemporaneously collected surveys of established metrics for quality of life (WHOQoLBREF) and general (global) state of health (numerical rating score 1-100).
The hypothesis is that the PROMIS-29 v2.1 questionnaire is a statistically valid and reliable means of assessing physical and mental health in a postpartum population.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Ontario
-
Toronto, Ontario, Canada, M5G1X5
- Mount Sinai Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Patients who deliver vaginally or by scheduled cesarean section at Mount Sinai Hospital.
Beskrivelse
Inclusion Criteria:
- 18 years old and over
- singleton births
- 37 or more weeks gestational age
- multiparous or nulliparous patients
- spontaneous vaginal delivery or scheduled cesarean delivery with labor analgesia or neuraxial anesthesia
- give informed written consent
Exclusion Criteria:
- refusal to take part
- are unable to give or have withdrawn consent
- patients unable to communicate fluently in English
- patients who are less than 18 years old
- patients who had fetal demise or severely morbid fetal conditions such as intubation, cooling, expected surgical correction of congenital anomaly during hospitalization (although NICU admissions will be included)
- patients who were admitted in ICU
- patients who had failed neuraxial analgesia such as replaced epidurals or failed spinal requiring conversion to general anesthesia
- patients who had general anesthesia for cesarean delivery as defined by "GETA", including sedatives and deep sedation if not intubated
- patients who had intrapartum cesarean or had assisted/operative (i.e. vacuum, forceps) vaginal delivery.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Vaginal delivery
Patients who have vaginal deliveries with neuraxial labour analgesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Andre navne:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Andre navne:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Andre navne:
|
|
Cesarean delivery
Patients who have a scheduled cesarean delivery with neuraxial anesthesia. |
PROMIS-29 is a survey designed to screen for pain, impairments in mood, physical function, and activities of daily living.
Andre navne:
The WHOQOL-BREF is a 26-item version of the 100-item WHOQOL-100 quality of life measure that addresses four quality of life domains: physical health, psychological health, social relationships and environment.
Andre navne:
The EQ-5D-3L1 is a generic measure of health status consisting of two parts. The first part assesses health in five dimensions: MOBILITY, SELFCARE, USUAL ACTIVITIES, PAIN / DISCOMFORT, ANXIETY/DEPRESSION. The second part of the questionnaire consists of a VAS on which the patient rates their perceived health from 0 (the worst imaginable health) to 100 (the best imaginable health).
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 24 hours
|
The PROMIS survey score at 24 hours postpartum |
24 hours
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 24 hours
|
The WHOQoLBREF survey score at 24 hours postpartum |
24 hours
|
|
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 24 hours
|
The EQ-5D-3L1 survey score at 24 hours postpartum |
24 hours
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 2 weeks
|
The PROMIS survey score at 2 weeks postpartum |
2 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 2 weeks
|
The WHOQoLBREF survey score at 2 weeks postpartum |
2 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 2 weeks
|
The EQ-5D-3L1 survey score at 2 weeks postpartum |
2 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 6 weeks
|
The PROMIS survey scores at 6 weeks postpartum |
6 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 6 weeks
|
The WHOQoLBREF survey score at 6 weeks postpartum |
6 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 6 weeks
|
The EQ-5D-3L1 survey score at 6 weeks postpartum |
6 weeks
|
|
PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System) survey score
Tidsramme: 12 weeks
|
The PROMIS survey score at 12 weeks postpartum |
12 weeks
|
|
WHOQoLBREF (World Health Organization Quality of Life Brief Version) survey score
Tidsramme: 12 weeks
|
The WHOQoLBREF survey score at 12 weeks postpartum |
12 weeks
|
|
EQ-5D-3L1 (not an acronym) survey score
Tidsramme: 12 weeks
|
The EQ-5D-3L1 survey score at 12 weeks postpartum |
12 weeks
|
Samarbejdspartnere og efterforskere
Efterforskere
- Ledende efterforsker: Ronald George, MD, MOUNT SINAI HOSPITAL
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 23-03
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .